Stay up-to-date with latest Insights of Companion Diagnostic market research offered by Allied Market Research. Check how key trends and emerging drivers are shaping this industry growth.
Companion diagnostics are a form of in-vitro diagnostics which provide data about the therapeutic reactions of patients for a particular treatment. Companion diagnostics market is still developing, and it is expected to reach a market value of $3.5 billion by 2020 from a market value of $1.1 billion in the year 2013, registering a CAGR of 20% during 2014-2020.
Companion diagnostics are in-vitro diagnostics that provide information about therapeutic responses of patients for a specific treatment. Companion diagnostics market is still nascent, and it is projected to reach $3.5 billion by 2020 from a base value of $1.1 billion in 2013, growing at a CAGR of 20% during 2014 to 2020. The global companion diagnostic market is segmented based on indication, technology and geography (North America, Europe, Asia Pacific and LAMEA). Read the Complete Report @ http://www.researchbeam.com/companion-diagnostic-technologies-market
Increase in burden of cancer globally, growing demand for personalized medicine and targeted therapy coupled with increase in adoption of drug diagnostics co-development model by industry players are the key factors driving the global companion diagnostics market.
Rise in prominence of personalized medicine, surge in cases of adverse drug reactions, and advancements in technologies for diagnostic techniques drive the growth in the global companion diagnostics market.
Research Nester released a report titled “Companion Animal Diagnostics Market: Global Demand Analysis & Opportunity Outlook 2029” which delivers detailed overview of the global companion animal diagnostics market in terms of market segmentation by technology, application, animal type, end-user and region.
As per Roche’s Personalized Healthcare Brochure, for every 10 patients with cancer treated, only an average of half will actually benefit from it. Read more: https://inkwoodresearch.com/companion-diagnostics-market-relevant-developments-overview/
Medical treatments are typically designed using uniform patterns, with patients with the same disease. Get more insights into the Companion Diagnostic market.
The global companion diagnostics market is anticipated to grow at a CAGR of 13.29%, and is estimated to reach $15441.90 million by 2030. Get Free Sample Report.
This report, from Stratview Research, studies the global clinical diagnostics market - companion diagnostics over the trend period of 2014 to 2017 and forecast period of 2018 to 2025.
Global Market Insights Inc. Add New Report Global Next Generation Sequencing Market to its database which covers the market landscape and its growth prospects over the coming years.
According to the latest research report by IMARC Group, The global companion diagnostics market size reached US$ 5.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 11.7 Billion by 2027, exhibiting a growth rate (CAGR) of 14.78% during 2022-2027. More Info:- https://www.imarcgroup.com/companion-diagnostics-market
This report describes the current technologies that are propelling the personalized medicine and companion diagnostic market. It examines the current genetic diagnostic tests and companion diagnostic assays that are in use by the medical and pharmaceutical industry today. Current developments in personalized medicine and the pharmacogenomics revolution are discussed.
Global Molecular Diagnostics Market is estimated to value over USD 12.6 billion by 2026 end and register a CAGR of over 8.9% during the forecast period 2019 to 2026.
Looking forward, the companion diagnostics market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- https://www.imarcgroup.com/companion-diagnostics-market
The new Companion Animal Diagnostic Market report offers a comprehensive study of the present scenario of the market coupled with major market dynamic. Also, it highlights the in-depth market analysis with the latest trends, drivers and its segments with respect to regional and country. Further, this report profiles top key players of the companion animal diagnostic and analyze their market share, strategic development and other development across the globe.
he global market for veterinary diagnostic is estimated to progress at 7.71% CAGR throughout 2019-2027 and will generate revenue of $5,129 million by the end of 2027. The heavy demand for livestock products is partly responsible for the steady increase in market growth over the years.Know more @ https://www.inkwoodresearch.com/reports/north-america-veterinary-diagnostics-market/
In IVD market oncology is one of the most sought-after segments by the manufacturers. Non-invasive cancer testing is expected to be a hot market in 2019. Qiagen, one of the global MNC, has been pioneering the use of liquid biopsy-based companion diagnostics as a less-invasive option to complement surgical biopsies for genomic profiling of cancers.
The global companion diagnostics market is anticipated to grow at a CAGR of 13.29%, and is estimated to reach $15441.90 million by 2030. Get Free Sample Report.
Research Beam added report on “Global Veterinary Diagnostics Market Outlook 2015 – 2022”. The Global Veterinary Diagnostics Market is estimated to be $2.8 billion in 2014 and is poised to reach $5.9 billion by 2022, growing at a CAGR of 9.8% from 2014 to 2022. Enquiry @ http://www.researchbeam.com/global-veterinary-diagnostics-outlook-2014-2022-market/enquire-about-report
The report "Companion Diagnostics Market by Product (Assays, Kits, Software & Services), Technology (PCR, NGS, ISH, IHC), Indication (Breast, Blood, Lung, Colorectal Cancer, Neurology Diseases), End User (Pharma Companies, CROs), Region - Global Forecast to 2026", the global companion diagnostics market is projected to reach USD 9.9 billion by 2026 from USD 5.5 billion in 2021, at a CAGR of 12.6%.
Big Market Research “Global Veterinary Diagnostics Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2022. Visit for more info @ http://www.bigmarketresearch.com/global-veterinary-diagnostics-outlook-2014-2022-market The report titled “Global Veterinary Diagnostics Market Outlook (2014-2022)” is an outcome of an in-depth market analysis, with the help of valuable inputs from industry experts. The report offers rational explanations for market dynamics along with detailed market estimations. The veterinary diagnostics market was evaluated at $2.8 billion in the year 2014 and would reach $5.9 billion by 2022, registering 9.8% CAGR during 2014-2022.
Global Veterinary Diagnostics Market was valued at USD 2.6 Billion in 2021 and is expected to reach USD 5.01 Billion by 2029, registering a CAGR of 8.55% during the forecast period of 2022-2029. https://www.databridgemarketresearch.com/reports/global-veterinary-diagnostics-market
Market Overview: Cancer Tissue Diagnostics Market Cancer tissue diagnostics play a pivotal role in oncology by facilitating accurate diagnosis, prognosis, and treatment selection based on tissue samples obtained from patients. The global cancer tissue diagnostics market is witnessing steady growth, driven by the increasing incidence of cancer, advancements in diagnostic technologies, and growing emphasis on personalized medicine.
Molecular diagnostics, a rapidly evolving segment of the healthcare industry, utilizes molecular biology techniques to analyze biological markers at the molecular level. This approach enables precise detection, diagnosis, and monitoring of various diseases, leading to personalized treatment strategies and improved patient outcomes. The global molecular diagnostics market demonstrates robust growth, driven by technological advancements, increasing prevalence of infectious diseases and cancer, and growing demand for rapid and accurate diagnostic solutions. The global molecular diagnostics market is forecast to expand at a CAGR of 6.2% and thereby increase from a value of US$23.2 Bn in 2024, to US$35.6 Bn by the end of 2031.
In Vitro Diagnostics Market USD 102.18 billion in 2024, poised for significant growth to USD 131.66 billion by 2029, with a notable CAGR of 5.20%. The catalyst for this growth is the global response to the COVID-19 pandemic.
According to the latest research report by IMARC Group, The global veterinary molecular diagnostics market size reached US$ 690.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,391.9 Million by 2032, exhibiting a growth rate (CAGR) of 7.9% during 2024-2032. More Info:- https://www.imarcgroup.com/veterinary-molecular-diagnostics-market
The report provides value and growth of the global personal therapeutics market from 2017-2021. Also historic figures back to 2014 are given to illustrate growth. As the personal targeted therapeutics market is part of the overall personalized medicine market, the companion diagnostics market is also included in the report
The Global Molecular Diagnostics Market is expected to attain a market size of $11.2 billion by 2022, growing at a CAGR of 8.6% during the forecast period. Full report: http://kbvresearch.com/global-molecular-diagnostics-market/
The Business Research Company offers veterinary infectious disease diagnostics market research report 2023 with industry size, share, segments and market growth
The global veterinary molecular diagnostics market is primarily driven by the widespread prevalence of zoonotic diseases and the surging pet ownership rates. Additionally, the growing animal husbandry activities and the rising concerns regarding food safety have augmented the product demand. Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: Visit the following link: https://www.imarcgroup.com/veterinary-molecular-diagnostics-market E-mail: sales@imarcgroup.com Contact: +91-120-415-5099
According to the latest research report by IMARC Group, The global veterinary molecular diagnostics market size reached US$ 634.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,064.8 Million by 2028, exhibiting a growth rate (CAGR) of 8.8% during 2023-2028. More Info:- https://www.imarcgroup.com/veterinary-molecular-diagnostics-market
Get more details @ http://bit.ly/2l3rNQ4 Key industry players contributing to global precision medicine market share include Pfizer, Roche, Covance, Novartis, Qiagen, Biocrates Life Sciences, Teva Pharmaceutical, Nanostring Technologies, Laboratory Corporation of America Holdings, Tepnel Pharma Services, Intomics, Ferrer InCode, Silicon Biosystems, Eagle Genomics, Medtronic, and Quest Diagnostics
The report provides a detailed understanding and analysis of how and why companies enter companion diagnostic partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors companion diagnostics technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
The global veterinary infectious disease diagnostics market size was USD 1.70 Billion in 2021 and is expected to register a revenue CAGR of 9.1% during the forecast period, according to the latest analysis by Emergen Research. Revenue growth of the veterinary infectious disease diagnostics market is driven by factors such as rising number of veterinary practitioners in developed countries, increasing prevalence of transboundary & zoonotic disease, and rising demand for pet insurance, advanced diagnostic devices, companion animal, and animal-derived food products.
Global Radiopharmaceutical Theragnostics Market Forecast to 2028 – COVID-19 Impact and Analysis – by Product Type, Radioisotope, Source, Application, Indication, and End User,” the market is expected to grow from US$ 1,814.58 million in 2022 to US$ 3,441.97 million by 2028; it is estimated to grow at a CAGR of 11.3% from 2022 to 2028
The vital factors aiding the expansion of this market embrace the increasing utility of biomarkers for diagnostic functions and new initiatives for biomarker analysis. The biomarker technologies market is predicted to achieve USD 74.51 billion in 2022, at a CAGR of 9.7% throughout the forecast period. The main target on biomarker analysis within the field of genetic science is growing with the arrival of innovative technologies.
Bharat Book presents the report on “Global Markets for Vaccine Technologies” (https://www.bharatbook.com/healthcare-market-research-reports-168817/global-vaccine-technologies.html). This report explores present and future strategies within the vaccine technology market, which is divided into vaccines for both humans and animals.
The molecular diagnostics market is expected to grow at a CAGR of 9.3% to reach USD 9,333.8 Million by 2020. High prevalence of infectious diseases and various types of cancer; increasing awareness and acceptance of personalized medicine and companion diagnostics; development of biomarkers; and advancements in molecular techniques, proteomics, and reformations in the reimbursement system are driving the growth of the market.
[320 Pages Report] Tissue Diagnostics Market report categories the Global market by Technology (Digital pathology & Workflow, Immunohistochemistry, in Situ Hybridization, Special Staining), Disease (Breast Cancer, Lymphoma, Gastric Cancer, Non Small Cell Lung Cancer , Prostate Cancer and Others), Product, End-Users & by Region (The Americas, Europe, BRIC, Japan & RoW)
The major players in the precision medicine market are Qiagen, Novartis AG, Medtronic, AstraZeneca plc., Quest Diagnostics, Thermo Fisher Scientific Inc...@@ https://bit.ly/2XCz1CE
The global precision medicine market is expected to grow from $62.75 billion in 2020 to $72.58 billion in 2021 at a compound annual growth rate (CAGR) of 15.7%.
This research report focuses on the qualitative data, market size, share, and growth of various segments and sub-segments, competitive landscape, and company profiles.
Get more details @ http://bit.ly/2ekRPfD Some of the major players of global precision medicine market are Intomics, F. Hoffmann-La Roche, NanoString Technologies, Laboratory Corporation of America Holdings, Biocrates Life Sciences, Teva Pharmaceutical, Tepnel Pharma Services, Novartis, Silicon Biosystems, Quest Diagnostics and Ferrer InCode.
The report provides a comprehensive study of global in-vitro diagnostic market covering regional markets and major segments. The competition in the global in-vitro diagnostic market is highly amalgamated with large players like Abbott, Siemens, Roche and Johnson and Johnson. All these companies have been profiled in the present report highlighting their key financials and business strategies for their long term growth. Complete report available at http://www.marketreportsonline.com/434386.html.